Sleep Disorders Trial, Recruiting NCT03736382 Sponsor: Wayne State University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT03736382
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a body mass index (a measure of body weight relative to height) under 40.
  • People between 18 and 60 years old.
  • People recently diagnosed with sleep apnea that has not yet been treated, with a moderate or less severe level of breathing disruptions during sleep and reasonable overnight oxygen levels.
  • People diagnosed with prehypertension or Stage 1 high blood pressure, as classified by the American Heart Association.
  • People who are not pregnant.
  • People with normal lung function.
  • People who drink little to no alcohol — no more than the equivalent of one glass of wine per day.
  • People with a regular day-time sleep and wake schedule, meaning no night shift work and no recent travel across time zones.
  • For one specific part of the study: people with an incomplete spinal cord injury at certain levels of the spine (C3 or below, and above T12), at least 36 months after the injury, who have some ability to move their ankles, knees, and hips and can take at least one step without another person's help (confirm with trial site).

Who may not be able to join:

  • People with any health condition other than high blood pressure and sleep apnea.
  • People currently taking medication for high blood pressure, or using sleep supplements such as melatonin.
  • People currently using a CPAP machine (a breathing device for sleep apnea) for more than 4 hours per night.
  • People who work night shifts or have recently travelled across multiple time zones.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jason H Mateika, Ph.D., Wayne State University

Phone: 313-576-4481

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wayne State University
Registry
ClinicalTrials.gov
Start date
15 November 2018
Est. completion
30 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in blood pressure measured during quiet wakefulness over the 24 hour period following mild intermittent hypoxia and sham protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov